Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Stress Response and Emergence Agitation in Laparoscopic Cholecystectomy
NCT02917018Phase 3Completed
- Sponsor
- Assiut University
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) and Surgical stress response (3 arms), sponsored by Assiut University. Primary endpoint: Serum Cortisol Level. Started May 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)Surgical stress response
Beyond the preview
Go deeper on NCT02917018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02917018.